ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Infectious Disease

Top Infectious Disease Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
YASSER OMRAN M.D.

Infectious Disease

23,434

$1.59M

566
448 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 42%

$68
Average prescription price

Avg: $300

RONALD SHUBERT M.D.

Infectious Disease

11,076

$594K

437
408 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 42%

$54
Average prescription price

Avg: $300

RONAL MANIS M.D.

Infectious Disease

9,540

$523K

459
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 42%

$55
Average prescription price

Avg: $300

VISWANATHAN CHOKKAVELU MD,FACP,FCCP

Infectious Disease

5,353

$410K

194
165 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 42%

$77
Average prescription price

Avg: $300

PAUL CAYAVEC DO

Infectious Disease

4,708

$894K

115
38 are 65+

40%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 42%

$190
Average prescription price

Avg: $300

ROBERT KALAYJIAN MD

Infectious Disease

4,489

$1.71M

133
19 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 42%

$381
Average prescription price

Avg: $300

BARBARA GRIPSHOVER MD

Infectious Disease

4,439

$1.91M

85
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 42%

$429
Average prescription price

Avg: $300

DIETHRA COX MD

Infectious Disease

4,356

$340K

270
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 42%

$78
Average prescription price

Avg: $300

VALSA MARIAPPURAM M.D.

Infectious Disease

4,201

$236K

363
329 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 42%

$56
Average prescription price

Avg: $300

PAMPOSH KAUL M.D.

Infectious Disease

4,060

$1.57M

112
11 are 65+

22%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 42%

$387
Average prescription price

Avg: $300

PETER GRUBBS M.D.

Infectious Disease

3,895

$1.96M

120
22 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 42%

$503
Average prescription price

Avg: $300

LISA HAGLUND M.D.

Infectious Disease

3,445

$1.37M

104
11 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 42%

$398
Average prescription price

Avg: $300

CARL FICHTENBAUM M.D.

Infectious Disease

3,211

$1.43M

83
13 are 65+

24%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 42%

$445
Average prescription price

Avg: $300

MICHAEL PARA M.D.

Infectious Disease

2,989

$2.14M

129
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 42%

$714
Average prescription price

Avg: $300

JUDITH FEINBERG M.D.

Infectious Disease

2,918

$956K

54
0 are 65+

39%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 42%

$328
Average prescription price

Avg: $300

SILVANIA NG MD

Infectious Disease

2,585

$280K

182
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 42%

$108
Average prescription price

Avg: $300

JANE EMERICK M.D.

Infectious Disease

2,561

$602K

230
155 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 42%

$235
Average prescription price

Avg: $300

CLAUDIU GEORGESCU M.D.

Infectious Disease

2,325

$1.36M

112
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 42%

$583
Average prescription price

Avg: $300

JAMES SMITH M.D.

Infectious Disease

2,217

$799K

389
277 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 42%

$360
Average prescription price

Avg: $300

JENNIFER HANRAHAN D.O.

Infectious Disease

2,213

$1.14M

112
34 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 42%

$517
Average prescription price

Avg: $300

ANDREW MURRY MD

Infectious Disease

2,181

$906K

145
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 42%

$415
Average prescription price

Avg: $300

CORRILYNN HILEMAN M.D.

Infectious Disease

2,162

$981K

93
19 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 42%

$454
Average prescription price

Avg: $300

ROGER ANDERSON MD

Infectious Disease

2,121

$413K

374
211 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 42%

$195
Average prescription price

Avg: $300

WENDY ARMSTRONG M.D.

Infectious Disease

2,035

$848K

235
16 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 42%

$417
Average prescription price

Avg: $300

MARK HERBERT M.D.

Infectious Disease

1,997

$393K

117
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 42%

$197
Average prescription price

Avg: $300

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank